These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27240777)

  • 21. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
    Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
    Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Repurposing: Claiming the Full Benefit from Drug Development.
    Kort E; Jovinge S
    Curr Cardiol Rep; 2021 May; 23(6):62. PubMed ID: 33961142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding site comparisons for target-centered drug discovery.
    Konc J
    Expert Opin Drug Discov; 2019 May; 14(5):445-454. PubMed ID: 30856011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico repositioning of approved drugs for rare and neglected diseases.
    Ekins S; Williams AJ; Krasowski MD; Freundlich JS
    Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug repositioning for orphan diseases.
    Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
    Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
    de Lera AR; Ganesan A
    Clin Epigenetics; 2016; 8():105. PubMed ID: 27752293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-Scale Prediction of Beneficial Drug Combinations Using Drug Efficacy and Target Profiles.
    Iwata H; Sawada R; Mizutani S; Kotera M; Yamanishi Y
    J Chem Inf Model; 2015 Dec; 55(12):2705-16. PubMed ID: 26624799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro screening for drug repositioning.
    Wilkinson GF; Pritchard K
    J Biomol Screen; 2015 Feb; 20(2):167-79. PubMed ID: 25527136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing Drugs to Target the Diabetes Epidemic.
    Turner N; Zeng XY; Osborne B; Rogers S; Ye JM
    Trends Pharmacol Sci; 2016 May; 37(5):379-389. PubMed ID: 26900045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work.
    Kumar R; Harilal S; Gupta SV; Jose J; Thomas Parambi DG; Uddin MS; Shah MA; Mathew B
    Eur J Med Chem; 2019 Nov; 182():111602. PubMed ID: 31421629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
    Parsons CG
    Neuropharmacology; 2019 Mar; 147():4-10. PubMed ID: 30165077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration.
    Lee S; Nemeño JG; Lee JI
    Tissue Eng Part B Rev; 2016 Oct; 22(5):341-357. PubMed ID: 26905221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.